MORRIS PLAINS, N.J., Dec. 3, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that the Company will present at the Oppenheimer 24th Annual Healthcare Conference on Tuesday, December 10th at 10:20 a.m. Eastern Time at Crowne Plaza Times Square Hotel in New York City. The presentation, which provides a corporate overview, can be downloaded simultaneously at http://www.immunomedics.com/pdfs/company-presentation.pdf.
Help employers find you! Check out all the jobs and post your resume.
